Inhibition of the SphK1/S1P signaling pathway by melatonin in mice with liver fibrosis and human hepatic stellate cells

DSpace/Manakin Repository

Inhibition of the SphK1/S1P signaling pathway by melatonin in mice with liver fibrosis and human hepatic stellate cells

Show full item record

Title: Inhibition of the SphK1/S1P signaling pathway by melatonin in mice with liver fibrosis and human hepatic stellate cells
Author: González-Fernández, Bárbara;Sánchez, Diana I.;Crespo, Irene;San-Miguel, Beatriz;Álvarez, Marcelino;Tuñón, María J.;González-Gallego, Javier
xmlui.dri2xhtml.METS-1.0.item-contributor: Instituto Universitario de Biomedicina (IBIOMED)
xmlui.dri2xhtml.METS-1.0.item-area: Otros
Abstract: The sphingosine kinase 1/sphingosine 1-phosphate (SphK1/S1P) system is involved in different pathological processes, including fibrogenesis. Melatonin abrogates activation of hepatic stellate cells (HSCs) and attenuates different profibrogenic pathways in animal models of fibrosis, but it is unknown if protection associates with its inhibitory effect on the SphK1/S1P axis. Mice in treatment groups received carbon tetrachloride (CCl4) 5 μL/g body wt i.p. twice a week for 4 or 6 weeks. Melatonin was given at 5 or 10 mg/kg/day i.p, beginning two weeks after the start of CCl4 administration. At both 4 and 6 weeks following CCl4 treatment, liver mRNA levels, protein concentration and immunohistochemical labelling for SphK1 increased significantly. S1P production, and expression of S1P receptor (S1PR)1, S1PR3 and acid sphingomyelinase (ASMase) were significantly elevated. However, there was a decreased expression of S1PR2 and S1P lyase (S1PL). Melatonin attenuated liver fibrosis, as shown by a significant inhibition of the expression of α-smooth muscle actin (α-SMA), transforming growth factor (TGF)-β and collagen (Col) Ι. Furthermore, melatonin inhibited S1P production, lowered expression of SphK1, S1PR1, SP1R3 and ASMase, and increased expression of S1PL. Melatonin induced a reversal of activated human HSCs cell line LX2, as evidenced by a reduction in α-SMA, TGF-β, and Col I expression. Melatonin-treated cells also exhibited an inhibition of the SphK1/S1P axis. Antifibrogenic effect of SphK1 inhibition was confirmed by treatment of LX2 cells with PF543. Abrogation of the lipid signaling pathway by the indole reveals novel molecular pathways that may account for the protective effect of melatonin in liver fibrogenesis
xmlui.dri2xhtml.METS-1.0.item-desfisica: 30 p.
Publisher: Wiley
xmlui.dri2xhtml.METS-1.0.item-citation: BioFactors, 2016
URI: http://hdl.handle.net/10612/5690
Date: 2016-01-23
xmlui.dri2xhtml.METS-1.0.item-tipo: info:eu-repo/semantics/preprint
Subject: Medicina. Salud
xmlui.dri2xhtml.METS-1.0.item-palclave: Hepatic stellate cells
Liver fibrosis
Melatonin
Sphingolipids
Exportar referencia a Refworks:


Files in this item

Files Size Format View
s1-ln24578967-Biofactors.pdf 1.327Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record

Search DSpace


Advanced Search

Browse

My Account

Statistics